Correlation Between Pfizer and 2023 ETF

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and 2023 ETF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and 2023 ETF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and 2023 ETF Series, you can compare the effects of market volatilities on Pfizer and 2023 ETF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 2023 ETF. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 2023 ETF.

Diversification Opportunities for Pfizer and 2023 ETF

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pfizer and 2023 is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and 2023 ETF Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 2023 ETF Series and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 2023 ETF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 2023 ETF Series has no effect on the direction of Pfizer i.e., Pfizer and 2023 ETF go up and down completely randomly.

Pair Corralation between Pfizer and 2023 ETF

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 2023 ETF. In addition to that, Pfizer is 2.18 times more volatile than 2023 ETF Series. It trades about -0.22 of its total potential returns per unit of risk. 2023 ETF Series is currently generating about -0.27 per unit of volatility. If you would invest  3,174  in 2023 ETF Series on August 30, 2024 and sell it today you would lose (139.00) from holding 2023 ETF Series or give up 4.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  2023 ETF Series

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
2023 ETF Series 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 2023 ETF Series has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, 2023 ETF is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pfizer and 2023 ETF Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and 2023 ETF

The main advantage of trading using opposite Pfizer and 2023 ETF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 2023 ETF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2023 ETF will offset losses from the drop in 2023 ETF's long position.
The idea behind Pfizer Inc and 2023 ETF Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance